筆針頭的全球市場 - 市場規模，佔有率，成長分析:各類型，不同治療，各流通管道 - 產業預測(2022年～2028年)

Global Pen Needles Market Size, Share, Growth Analysis, By Type(Standard Pen Needles, Safety Pen Needles), By Therapy(Insulin, GLP 1), By Distribution Channel(Retail, Non-Retail) - Industry Forecast 2022-2028

出版日期: 2023年04月13日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球筆針頭的市場規模預測將從2022年的25億美元到2030年達到42億美元，在預測期間(2023年～2030年)時預計將以年複合成長率6.8％的速度成長。由於糖尿病流行和對微創藥物輸送設備的需求增加，預計未來幾年市場將顯著增長。

本報告提供全球筆針頭市場相關調查分析，提供市場動態及預測，市場區隔分析，企業簡介等資訊。

Novo Nordisk A/S (Denmark)
Becton, Dickinson, and Company (US)
Terumo Corp. (Japan)
Owen Mumford Ltd. (UK)
Ypsomed (Switzerland)
B. Braun Melsungen AG (Germany)
HTL-STREFA (Poland)
UltiMed, Inc. (US)
Allison Medical, Inc. (US)
Artsana S.p.A. (Italy)
ECR Pharmaceuticals Co., Ltd. (US)
CR Pharmaceuticals Co., Ltd. (China)

簡介目錄

Product Code: SQSG35A2057

Pen Needles Market size was valued at USD 2.34 billion in 2021 and is poised to grow from USD 2.5 billion in 2022 to USD 4.2 billion by 2030, growing at a CAGR of 6.8% in the forecast period (2023-2030).

The global pen needles market is expected to grow significantly in the coming years due to the rising prevalence of diabetes and the increasing demand for minimally invasive drug delivery devices. Pen needles are used in insulin delivery systems and are preferred by patients due to their ease of use and reduced pain. The market is also driven by technological advancements and innovations in pen needle design, such as the development of safety pen needles. The Asia Pacific region is expected to witness the highest growth due to increasing awareness and access to healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of Pen Needles market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global pen needles market is segmented based on type, therapy, distribution channel, and region. Based on type, the market is segmented into standard pen needles and safety pen needles. Based on therapy, the market is segmented into Insulin, GLP 1, and Growth Hormone. Based on distribution channels, the market is segmented into retail and non-retail. Based on region, the global Pen Needles market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The prevalence of chronic diseases has been on the rise, leading to an increased need for daily or weekly pen injections to treat conditions such as diabetes, osteoporosis, cardiovascular disease, and multiple sclerosis. Pen injectors have become the preferred method for administering injectable medications due to their simplicity, dependability, and ability to be self-administered. The removable needle of the pen injector plays a crucial role in drug administration, with its length and sharpness being essential factors to consider. As the number of patients with chronic diseases continues to grow, there is a greater emphasis on developing pen needle technologies to improve patient adherence and accommodate the increasing patient numbers. These factors are contributing to the rising demand for the global pen needle market during the analysis period.

Restrain

Although pen needles are a convenient way to administer medication, they have drawbacks such as needlestick injuries, infections, hyperglycemia, and discomfort. Insulin pen therapy may lead to hyperglycemia in some patients due to the inability to adjust the dose. As a result, there has been a shift in diabetes treatment from insulin pens to insulin pumps, which can automatically suspend insulin delivery and reduce the risk of hypoglycemia. These factors have significantly limited market growth during the analysis period.

Trend

The current trend in the market is the popularity of shorter and thinner pen needles, which is driving the growth of the pen needles market. These needles are particularly suitable for obese individuals and have proven to be a better alternative to syringes and bottles for administering drugs. Compared to traditional syringes, pen needles have a more precise and sharp tip, making self-administration easier and safer for diabetic patients. As a result, the demand for pen needles is expected to increase during the analysis period.